NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82

Posted on:17 Mar 2016 09:14:27
NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82
17 March 2016 Current Affairs: The National Research Development Corporation (NRDC) on 16 March 2016 signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an Ayurvedic formulation for prevention and management of diabetes.The agreement will now allow Kudos Laboratories India to commercialize the drug under their trade name with due acknowledgement to Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India.Ayush-82 was developed by CCRAS. The CCRAS is an apex organization for research in Ayurveda under the Ministry of AYUSH. Kudos Laboratories India, a 100 years old organization, is engaged in marketing, manufacturing and exports of the widest range of Ayurvedic / Herbal products and range of Cosmetics.The company holds G.M.P & ISO Certifications.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs September 2017

23 SEPTEMBER
NEWS
22 SEPTEMBER
NEWS
21 SEPTEMBER
NEWS
20 SEPTEMBER
NEWS

Current Affairs August 2017

31 AUGUST
NEWS
30 AUGUST
NEWS
29 AUGUST
NEWS
28 AUGUST
NEWS

Current Affairs July 2017

31 JULY
NEWS
29 JULY
NEWS
28 JULY
NEWS
27 JULY
NEWS